Navigation Links
UCLA-industry partnership to develop, commercialize new nanotechnology
Date:12/17/2007

The California NanoSystems Institute (CNSI) at UCLA and NanoPacific Holdings Inc. have announced a partnership to commercialize a mechanized, nanoparticle-based technology that could lead to prolonged lives of enhanced quality for millions of cancer sufferers.

Under the terms of the partnership, NanoPacific will receive exclusive license to key intellectual property owned by UCLA and developed at the CNSI's Nano Machine Center. The newly formed company will provide funding for further research at the center to broaden the scope of the technology for a diverse range of applications.

"This partnership is a prime example of how the CNSI will fulfill its mission," said UCLA Chancellor Gene Block. "Working with industry to bring new developments in technology and biotechnology into the marketplace for the benefit of the people of California is exactly why the CNSI was established."

The first application under the new partnership will involve the use of the technology for the targeted delivery of Food and Drug Administration-approved chemotherapeutic agents to cancer cells. Because of their unique properties, the mechanized nanoparticles can be preprogrammed to seek out cancer cells specifically while avoiding the body's other rapidly growing cells. In addition, the robot-like nanoparticles allow for the triggered release of cancer drugs that are currently difficult to administer intravenously because of their low solubilities in the blood stream.

The delivery mechanism consists of porous nanoparticles that are capable of storing and selectively releasing small drug molecules via nanoscale gates that can be opened and closed at will on the particles' surfaces. In this way, drugs can be loaded and unloaded in a selective manner in different environments. By equipping the nanoparticle surfaces with specific tags to preferentially target cancer cells, diseased cells can be destroyed selectively without affecting healthy on
'/>"/>

Contact: Jennifer Marcus
jmarcus@cnsi.ucla.edu
310-267-4839
University of California - Los Angeles
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
2. BDSI secures US commercial partnership for BEMA Fentanyl with Meda AB
3. Survey From The Partnership and MetLife Foundation Reveals Important Role Todays Grandparents Play in Teens Lives
4. B-Line Medical(TM) and the Center for Medical Simulation Announce Partnership
5. NASN Joins Partnership to Fight Chronic Disease
6. Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership
7. MetLife Foundation Begins New Phase of Award-Winning Parenting Skills Campaign in Collaboration with the Partnership for a Drug-Free America(R)
8. Stille and Enova Form Strategic Partnership to Introduce Worlds Brightest LED Cordless Surgical Headlights Into Europe and Japan
9. Partnership to Fight Chronic Disease Announces Ideas for Change in Health Care
10. Partnership for a Drug-Free America and Colorado Springs Police Department Introduce Methamphetamine Prevention Program to Colorado Law Enforcement
11. Anthem Blue Cross and Blue Shield Partnership Plan Wins Nevada Immunization Award

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)...HINGTON, Nov. 21 DNC Ch...ter the Senate voted to begin full debate of healt...p://www.newscom.com/cgi-bin/prnh/20080519/DNCLOGO ... step on the road to enacting health insurance ref...ators will now have an opportunity to debate the h...
(Date:11/21/2009)...SHINGTON, Nov. 21 A reg...e onchocerciasis (river blindness) in the Americas...isease in recent years, as evidenced by a 31% decr...rug administration in six endemic countries. Resu... of the American Society of Tropical Medicine and ...
(Date:11/21/2009)... NH based medical credentialing software...ustry to form a partnerhsip with Amerinet, Inc., t...tnership will help to transform quality care withi... (Vocus) November 21, 2009 -- ISG Group, LLC, doi...new agreement with Amerinet Inc., a leading nation...
(Date:11/21/2009)... Eric J. Hall, president and chief execu...ica (AFA) issued the following statement regarding...s part of the new annual wellness for Medicare ben...ordable Care Act" that was introduced last ni...B) November 21, 2009 -- Eric J. Hall, president an...
(Date:11/20/2009)...eering Neurologist Closer to Understanding Brain W...wswire-USNewswire/ -- Dr. Jeremy Schmahmann, Profe...urologist at the Massachusetts General Hospital in...aboratory,s research on the new field of study cal...oundation. ,, Dr. Schmahmann is an award-winnin...
Breaking Medicine News(10 mins):Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2
...research team led by the National Human Genome Res... experimental anti-cancer drugs also shows promise...c disorder that causes premature aging. // The... and other conditions. It could also provide a pot...
...aking behaviors, like over speeding, more in compa...of opposite sex. The study was published on-l...revention. // The findings indicate that tee...nd the adults who care about them-that they need t...
...ercent of all couples trying to conceive that is, ...baby have a problem with conception. With this ... opting for assisted reproductive treatments is in...y of patients regarding the treatment is one of th...
... word like "wheeze" can activate two brain regions...tivity may be associated with more severe asthma s...// The study reveals a functional link between emo...at stress and emotional turmoil adversely affect p...
...ake head-and-neck cancer patients feel as if they ...cipating that the treatment may later cause diffic... // feeding tube through the stomach wall. This ho...that feeding tube patients were reporting more tro...
...ication of Helicobacter may not prevent future agg... left behind. This was reported by Research led by... of Medicine. The paper by Mueller et al., "T... issue of The American Journal of Pathology. ...
Other Medicine News:Health News:Will anxiety regarding fertility treatment affect the chances of conception? 2Health News:Asthma aggravated by thought processes 2Health News:Helicobacter pylori Antibiotic Treatment of Peptic Ulcer May not Prevent Gastric lymphomas 2
(Date:11/20/2009)...NG, Pa., Nov. 20 In res...estions why currently available medications design...ored, ECRI Institute, an independent nonprofit org...n Finasteride for Prevention of Prostate Cancer ... New York Times article, " Drugs to Deter Some Ca...
(Date:11/19/2009)...., Nov. 19 BioCryst Phar... the pricing of a public offering of 5,000,000 sha...ing in gross proceeds of $48.75 million. All of t...o an effective shelf registration statement previo...sion. BioCryst has also granted the underwriters ...
(Date:11/19/2009)... 19 Riverain Medical announced tod...g Canadian medical imaging distributor Christie Gr...nGuard Chest Xray CAD. The exclusive agreement wil...ucts to the Canadian market through Christie Group...SoftView Enhanced Chest Imaging increases the clar...
Breaking Medicine Technology:ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2Vivacare Delivers Medication Information to Patients through Doctor Websites 59336 1Vivacare Delivers Medication Information to Patients through Doctor Websites 59336 2Vivacare Delivers Medication Information to Patients through Doctor Websites 59336 3Ergobiz Announces The Mobo Ergonomic Computer Station 59334 1Ergobiz Announces The Mobo Ergonomic Computer Station 59334 2Ergobiz Announces The Mobo Ergonomic Computer Station 59334 3ERISAclaim com Announced the Nation 26apos 3Bs First Certification Program for the ERISA Claim Appeal Specialist for Healthcare Providers and Managed 59332 1ERISAclaim com Announced the Nation 26apos 3Bs First Certification Program for the ERISA Claim Appeal Specialist for Healthcare Providers and Managed 59332 2ERISAclaim com Announced the Nation 26apos 3Bs First Certification Program for the ERISA Claim Appeal Specialist for Healthcare Providers and Managed 59332 3ERISAclaim com Announced the Nation 26apos 3Bs First Certification Program for the ERISA Claim Appeal Specialist for Healthcare Providers and Managed 59332 4
...enics,Limited ("Phosphagenics") (ASX: POH; AIM: PS...ay announced that their joint phase 2 human clinic...s, Phospha E(R) in the,management of metabolic syn...ralia., Based on current recruitment rates of stu...hich is fully funded by Nestle, is expected to,be ...
...ogram,s Ongoing Phase 2a ...armacopeia,(Nasdaq: PCOP ), an innovator in the d...herapeutics, today announced the nomination of PS0...ts internal CCR1 discovery,program. PS031291 is a ...okine receptor CCR1, which has been implicated to ...
Other Medicine Technology:Update on Progression of Phosphagenics and Nestle Nutrition's Phospha E(R) Trial 2Update on Progression of Phosphagenics and Nestle Nutrition's Phospha E(R) Trial 3Update on Progression of Phosphagenics and Nestle Nutrition's Phospha E(R) Trial 4Pharmacopeia Nominates Novel Chemokine Receptor Antagonist for Development 2Pharmacopeia Nominates Novel Chemokine Receptor Antagonist for Development 3Pharmacopeia Nominates Novel Chemokine Receptor Antagonist for Development 4
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
Medicine Products: